Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer

被引:0
|
作者
Fujimoto, N [1 ]
Ueoka, H [1 ]
Kiura, K [1 ]
Tabata, M [1 ]
Bessho, A [1 ]
Takata, I [1 ]
Sunami, K [1 ]
Hiramatsu, Y [1 ]
Ikeda, K [1 ]
Tanimoto, M [1 ]
Harada, M [1 ]
机构
[1] Okayama Univ, Sch Med, Dept Internal Med 2, Okayama 7008558, Japan
关键词
dose-intensive chemotherapy; autologous blood progenitor cell transplantation (ABPCT); small cell lung cancer; second-line chemotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report two cases with small cell lung cancer (SCLC) receiving multicyclic dose-intensified chemotherapy (DI-CT) supported by autologous blood progenitor cell transplantation (ABPCT). Both cases were initially treated with cisplatin (CDDP), etoposide (ETP) and concurrent thoracic irradiation, however they had recurrent disease within a year. After receiving conventional chemotherapy, they underwent multicyclic DI-CT consisting of CDDP, ETP and ifosfamide supported by G-CSF and ABPCT. Definite regression of the tumors was observed. Severe neutropenia and thrombocytopenia were encountered but they were reversible and no life-threatening complications were experienced. These results suggest the feasibility and effectiveness of multicyclic DI-CT and the usefulness of ABPCT as a treatment option for relapsed SCLC.
引用
收藏
页码:4229 / 4232
页数:4
相关论文
共 50 条
  • [1] A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer
    M Takahashi
    H Yoshizawa
    H Tanaka
    J Tanaka
    H Kagamu
    K Ito
    T Shimbo
    D Chou
    M Wakabayashi
    E Suzuki
    K Sakai
    M Arakawa
    F Gejyo
    Bone Marrow Transplantation, 2000, 25 : 5 - 11
  • [2] A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer
    Takahashi, M
    Yoshizawa, H
    Tanaka, H
    Tanaka, J
    Kagamu, H
    Ito, K
    Shimbo, T
    Chou, D
    Wakabayashi, M
    Suzuki, E
    Sakai, K
    Arakawa, M
    Gejyo, F
    BONE MARROW TRANSPLANTATION, 2000, 25 (01) : 5 - 11
  • [3] Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer
    Kubota, K
    Nishiwaki, Y
    Kakinuma, R
    Hojo, F
    Matsumoto, T
    Ohmatsu, H
    Sekine, I
    Yokozaki, M
    Goto, K
    Ebi, N
    Kodama, T
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 292 - 296
  • [4] Multicyclic dose-intensive chemotherapy with circulating progenitor cell support for high-risk primary breast cancer
    Danova, M
    Perotti, C
    Mora, O
    Lucotti, C
    Torretta, L
    Comolli, G
    Riccardi, A
    Salvaneschi, L
    Ascari, E
    ONCOLOGY REPORTS, 1998, 5 (02) : 427 - 429
  • [5] Dose-intensive therapy in small cell lung cancer
    Elias, A
    CHEST, 1998, 113 (01) : 101S - 106S
  • [6] Dose-intensive chemotherapy in extensive-stage small-cell lung cancer
    S. Negoro
    Noriyuki Masuda
    Kiyoyuki Furuse
    Nagahiro Saijo
    Masahiro Fukuoka
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S70 - S73
  • [7] Multicyclic dose-intensive carboplatin/paclitaxel supported by haemopoietic progenitor cell reinfusion in whole blood: A phase I study.
    Pettengell, R
    Woll, PJ
    Warburton, S
    Carmichael, J
    BRITISH JOURNAL OF CANCER, 1999, 80 : 14 - 14
  • [8] Dose-intensive chemotherapy in extensive-stage small-cell lung cancer
    Negoro, S
    Masuda, N
    Furuse, K
    Saijo, N
    Fukuoka, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) : S70 - S73
  • [9] DOSE-INTENSIVE THERAPY WITH AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN BREAST-CANCER
    KOTASEK, D
    SAGE, RE
    DALE, BM
    NORMAN, JE
    BOLTON, A
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1994, 24 (03): : 288 - 295
  • [10] MULTICYCLIC, DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED BY SEQUENTIAL REINFUSION OF HEMATOPOIETIC PROGENITORS IN WHOLE-BLOOD
    PETTENGELL, R
    WOLL, PJ
    THATCHER, N
    DEXTER, TM
    TESTA, NG
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) : 148 - 156